{"nctId":"NCT01303861","briefTitle":"Concurrent Bupropion / Varenicline for Smoking Cessation","startDateStruct":{"date":"2011-03"},"conditions":["Nicotine Dependence"],"count":702,"armGroups":[{"label":"varenicline","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Varenicline"]},{"label":"Nicotine Patches only","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Nicotine patches"]},{"label":"Nicotine Patches with Nicotine Inhaler","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Nicotine patches","Drug: Nicotine Inhaler"]},{"label":"varenicline with bupropion","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Varenicline","Drug: Bupropion"]}],"interventions":[{"name":"Varenicline","otherNames":["Chantix"]},{"name":"Bupropion","otherNames":["Zyban"]},{"name":"Nicotine patches","otherNames":["Nicoderm"]},{"name":"Nicotine Inhaler","otherNames":["Nicotrol Inhaler"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 18-65 years old;\n* smoked an average of at least 10 cigarettes per day for three cumulative years;\n* have an expired air CO reading assessed at screening of at least 10ppm;\n* express a desire to quit smoking within the next 30 days.\n\nExclusion Criteria:\n\n* Hypertension (systolic \\>140 mm Hg, diastolic \\>100 mm Hg, coupled with a history of hypertension); subjects with no previous diagnosis of hypertension may have a screening blood pressure up to 160/100.\n* Hypotension with symptoms (systolic \\<90 mm Hg, diastolic \\<60 mm Hg).\n* Coronary heart disease;\n* Lifetime history of heart attack;\n* Cardiac rhythm disorder (irregular heart rhythm);\n* Chest pains (unless history, exam, and ECG clearly indicate a non-cardiac source);\n* Cardiac (heart) disorder (including but not limited to valvular heart disease, heart murmur, heart failure);\n* History of skin allergy;\n* Active skin disorder (e.g., psoriasis) within the last five years, except minor skin conditions (including but not limited to facial acne, minor localized infections, and superficial minor wounds);\n* Liver or kidney disorder (except kidney stones, gallstones);\n* Gastrointestinal problems or disease other than gastroesophageal reflux or heartburn;\n* Active ulcers in the past 30 days;\n* Currently symptomatic lung disorder/disease (including but not limited to chronic obstructive pulmonary disease (COPD), emphysema, and asthma);\n* Brain abnormality (including but not limited to stroke, brain tumor, and seizure disorder);\n* Migraine headaches that occur more frequently than once per week;\n* Recent, unexplained fainting spells;\n* Problems giving blood samples;\n* Diabetes treated with insulin; non-insulin treated diabetes (unless glucose is less than 180mg/dcl and HbA1c is less than 7%);\n* Current cancer or treatment for cancer in the past six months (except basal or squamous cell skin cancer);\n* Other major medical condition;\n* Current psychiatric disease (with the exception of anxiety disorders, obsessive compulsive disorder (OCD) and ADHD);\n* Suicidal ideation (within the past 10 years) or lifetime occurrence of attempted suicide;\n* Current depression;\n* Bulimia or anorexia;\n* Pregnant or nursing mothers;\n* Alcohol abuse;\n* Use of Opiate medications for pain or sleep in the past 14 days;\n* Significant adverse reaction to nicotine patches, nicotine inhalers, bupropion / Wellbutrin / Zyban or Chantix / Varenicline in the past.\n* Use (within the past 30 days) of:\n* Illegal drugs (or if the urine drug screen is positive),\n* Experimental (investigational) drugs;\n* Psychiatric medications including antidepressants, anti-psychotics or any other medications that are known to affect smoking cessation (e.g. clonidine);\n* Smokeless tobacco (chewing tobacco, snuff), cigars, pipes or e-cigarettes;\n* Wellbutrin, bupropion, Zyban, Chantix, nicotine replacement therapy or any other smoking cessation aid.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Four-week Continuous Abstinence From Cigarette Smoking","description":"The primary dependent measures will be continuous four-week abstinence from weeks 8-11 post target quit date, defined as a self-report of no smoking confirmed by expired air carbon monoxide.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25.93","spread":null},{"groupId":"OG001","value":"46.94","spread":null},{"groupId":"OG002","value":"43.64","spread":null},{"groupId":"OG003","value":"39.82","spread":null}]}]}]},{"type":"SECONDARY","title":"Seven Day Point Abstinence From Cigarette Smoking","description":"Secondary outcome will include point abstinence (no smoking in the previous 7-day) at 6 months post-quit.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"12","spread":null},{"groupId":"OG002","value":"6","spread":null},{"groupId":"OG003","value":"29","spread":null}]}]}]},{"type":"SECONDARY","title":"Continuous Cigarette Abstinence From Quit Date","description":"Secondary outcome will include continuous abstinence from quit date to end of treatment (week 11).","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"13","spread":null},{"groupId":"OG002","value":"15","spread":null},{"groupId":"OG003","value":"17","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":109},"commonTop":["Vivid Dreams","Change in Taste","Insomnia","Thirst","Irritability"]}}}